Hey blue,
Since the ALA 101 in vivo data got delayed you would assume that they found something of interest in the data? I’m assuming ALA could not discuss what was found? but can tell investors they wouldn’t be going forward if it showed bad results.
Would they need to restart the trials all over again? Or would it potentially be faster in getting results due to having a lot of it in place and ready to go?
Cheers
Hey blue, Since the ALA 101 in vivo data got delayed you would...
-
- There are more pages in this discussion • 91 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ALA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
14.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $152.3M | |||
| Open | High | Low | Value | Volume |
| 14.5¢ | 15.0¢ | 14.0¢ | $161.1K | 1.109M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 16330 | 14.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 14.5¢ | 67603 | 2 |
View Market Depth
| Last trade - 16.10pm 27/06/2024 (20 minute delay) ? |
| ALA (ASX) Chart |